サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：臓器移植拒絶反応治療薬市場- 薬剤クラス別、移植タイプ別、流通チャネル別、世界予測、2023-2032年
市場調査レポート
商品コード
1370638

臓器移植拒絶反応治療薬市場- 薬剤クラス別、移植タイプ別、流通チャネル別、世界予測、2023-2032年

Organ Transplant Rejection Medication Market - By Drug Class (Calcineurin Inhibitor, Antibodies, Antiproliferative Agent), Transplant Type (Kidney, Liver, Heart), Distribution Channel (Hospital, Retail Pharmacies), Global Forecast, 2023-2032
出版日: | 発行: Global Market Insights Inc. | ページ情報: 英文 120 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.58円
臓器移植拒絶反応治療薬市場- 薬剤クラス別、移植タイプ別、流通チャネル別、世界予測、2023-2032年
出版日: 2023年08月30日
発行: Global Market Insights Inc.
ページ情報: 英文 120 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

臓器移植拒絶反応治療薬の市場規模は、慢性疾患の頻度上昇と臓器移植の必要性の高まりに起因して、2023年から2032年にかけてCAGR 3.2％で拡大すると予測されています。

生活習慣病や末期腎不全、肝不全などの疾患負担の増大が、効果的な拒絶反応治療薬の需要急増に寄与しています。

さらに、臓器拒絶反応と闘うために調整された革新的な免疫抑制療法の継続的な開拓とともに、患者の転帰を最適化することに医療提供者が重点を置いていることが、市場の成長を後押ししています。一例を挙げると、2023年9月、エレドン・ファーマシューティカルズ社は、同社の実験的抗CD40抗体であるtegoprubartが、史上2例目となるブタから人への遺伝子操作心臓移植後の慢性免疫抑制治療の主要成分として採用されたことを明らかにしました。

臓器移植拒絶反応治療薬業界は、移植タイプ、流通チャネル、薬剤クラス、地域別に分類されます。

2023年から2032年にかけて、抗体薬剤クラス別の市場シェアが大きく伸びると予測されています。世界中で臓器移植手術の件数が急増しており、患者の予後を確実に改善するための効果的な免疫抑制療法の必要性が高まっています。最近では、特異性を高め副作用を軽減した抗体が広く注目されています。さらに、抗体ベースの治療法の最適化に焦点を当てた研究開発イニシアチブが進行中であることも、同分野の成長を支えています。

流通チャネル別では、小売薬局セグメントの臓器移植拒絶反応治療薬市場が2032年まで力強い成長を記録すると予測されます。小売薬局の広範なネットワークは、そのアクセスのしやすさと患者中心のアプローチと相まって、臓器拒絶反応治療薬の流通を著しく促進しています。さらに、個人に合わせたカウンセリングや投薬管理サービスに対するニーズの高まりが、臓器移植拒絶反応治療薬の普及に寄与しています。

地域的には、アジア太平洋地域の臓器移植拒絶反応治療薬産業は、臓器移植手術の普及率の増加と慢性疾患の罹患率の上昇に後押しされて、2032年まで大幅な成長を示すと推定されています。大規模なヘルスケア投資と医療インフラの進歩が、移植拒絶反応を予防する効果的な免疫抑制療法に対する需要の拡大に寄与しています。さらに、大規模な患者プールの存在と、医療アクセスを強化するための政府の支援的イニシアチブの高い実施は、この地域の産業展望を拡大すると思われます。

目次

第1章 調査手法と調査範囲

第2章 エグゼクティブサマリー

第3章 臓器移植拒絶反応治療薬市場の洞察

  • 業界情勢
  • 業界への影響要因
    • 促進要因
      • 慢性疾患による臓器移植の増加
      • 臓器移植と組織工学の技術的進歩
    • 業界の潜在的リスク＆課題
      • 臓器移植手術の高コスト
      • 移植用臓器の入手可能性の低さ
  • 成長可能性分析
  • COVID-19影響分析
  • 規制状況
  • ポーター分析
  • PESTEL分析

第4章 競合情勢

  • イントロダクション
  • 企業マトリックス分析
  • 競合ポジショニング・マトリックス
  • 戦略ダッシュボード

第5章 臓器移植拒絶反応治療薬市場推計・予測：薬剤クラス別、2018年～2032年

  • 主要動向：薬剤クラス別
  • カルシニューリン阻害薬
  • 抗体
  • 抗増殖剤
  • mTOR阻害剤
  • ステロイド

第6章 臓器移植拒絶反応治療薬市場推計・予測：移植タイプ別、2018年～2032年

  • 主要動向：移植タイプ別
  • 腎臓
  • 肝臓
  • 心臓
  • 肺
  • 膵臓
  • その他の移植

第7章 臓器移植拒絶反応治療薬市場推計・予測：流通チャネル別、2018年～2032年

  • 主要動向：流通チャネル別
  • 病院薬局
  • 小売薬局
  • オンライン薬局

第8章 臓器移植拒絶反応治療薬市場推計・予測：地域別、2018年～2032年

  • 主要動向：地域別
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イタリア
    • スイス
    • その他欧州
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他ラテンアメリカ
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • その他中東とアフリカ

第9章 企業プロファイル

  • Astellas Pharma Inc.
  • Sanofi
  • Bristol-Myers Squibb Company
  • Novartis AG
  • F. Hoffmann-La Roche Ltd
  • Accord Healthcare Ltd
  • Viatris, Inc.
  • Dr. Reddy's Laboratories Ltd
  • Veloxis Pharmaceuticals A/S
  • GlaxoSmithKline plc
図表

Data Tables

  • TABLE 1 Product mapping
  • TABLE 2 Market revenue, by drug class (2022)
  • TABLE 3 Market revenue, by transplant type (2022)
  • TABLE 4 Market revenue, by distribution channel (2022)
  • TABLE 5 Market share, by region (2022)
  • TABLE 6 Global organ transplant rejection medicine market size, by region, 2018 - 2022 (USD Million)
  • TABLE 7 Global organ transplant rejection medicine market size, by region, 2023 - 2032 (USD Million)
  • TABLE 8 Global organ transplant rejection medicine market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 9 Global organ transplant rejection medicine market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 10 Global organ transplant rejection medicine market size, by transplant type, 2018 - 2022 (USD Million)
  • TABLE 11 Global organ transplant rejection medicine market size, by transplant type, 2023 - 2032 (USD Million)
  • TABLE 12 Global organ transplant rejection medicine market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 13 Global organ transplant rejection medicine market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 14 Industry impact forces
  • TABLE 15 Competitive benchmarking of major market players
  • TABLE 16 Competitive positioning matrix: Classification criteria
  • TABLE 17 Strategic outlook matrix: Classification criteria
  • TABLE 18 Calcineurin inhibitors market size, by region, 2018 - 2022 (USD Million)
  • TABLE 19 Calcineurin inhibitors market size, by region, 2023 - 2032 (USD Million)
  • TABLE 20 Antibodies market size, by region, 2018 - 2022 (USD Million)
  • TABLE 21 Antibodies market size, by region, 2023 - 2032 (USD Million)
  • TABLE 22 Antiproliferative agents market size, by region, 2018 - 2022 (USD Million)
  • TABLE 23 Antiproliferative agents market size, by region, 2023 - 2032 (USD Million)
  • TABLE 24 mTOR inhibitor market size, by region, 2018 - 2022 (USD Million)
  • TABLE 25 mTOR inhibitor market size, by region, 2023 - 2032 (USD Million)
  • TABLE 26 Steroids market size, by region, 2018 - 2022 (USD Million)
  • TABLE 27 Steroids market size, by region, 2023 - 2032 (USD Million)
  • TABLE 28 Kidney market size, by region, 2018 - 2022 (USD Million)
  • TABLE 29 Kidney market size, by region, 2023 - 2032 (USD Million)
  • TABLE 30 Liver market size, by region, 2018 - 2022 (USD Million)
  • TABLE 31 Liver market size, by region, 2023 - 2032 (USD Million)
  • TABLE 32 Heart market size, by region, 2018 - 2022 (USD Million)
  • TABLE 33 Heart market size, by region, 2023 - 2032 (USD Million)
  • TABLE 34 Lung market size, by region, 2018 - 2022 (USD Million)
  • TABLE 35 Lung market size, by region, 2023 - 2032 (USD Million)
  • TABLE 36 Pancreas market size, by region, 2018 - 2022 (USD Million)
  • TABLE 37 Pancreas market size, by region, 2023 - 2032 (USD Million)
  • TABLE 38 Other transplant types market size, by region, 2018 - 2022 (USD Million)
  • TABLE 39 Other transplant types market size, by region, 2023 - 2032 (USD Million)
  • TABLE 40 Hospital pharmacies market size, by region, 2018 - 2022 (USD Million)
  • TABLE 41 Hospital pharmacies market size, by region, 2023 - 2032 (USD Million)
  • TABLE 42 Retail pharmacies market size, by region, 2018 - 2022 (USD Million)
  • TABLE 43 Retail pharmacies market size, by region, 2023 - 2032 (USD Million)
  • TABLE 44 Online pharmacies market size, by region, 2018 - 2022 (USD Million)
  • TABLE 45 Online pharmacies market size, by region, 2023 - 2032 (USD Million)
  • TABLE 46 North America organ transplant rejection medicine market size, by country, 2018 - 2022 (USD Million)
  • TABLE 47 North America organ transplant rejection medicine market size, by country, 2023 - 2032 (USD Million)
  • TABLE 48 North America organ transplant rejection medicine market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 49 North America organ transplant rejection medicine market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 50 North America organ transplant rejection medicine market size, by transplant type, 2018 - 2022 (USD Million)
  • TABLE 51 North America organ transplant rejection medicine market size, by transplant type, 2023 - 2032 (USD Million)
  • TABLE 52 North America organ transplant rejection medicine market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 53 North America organ transplant rejection medicine market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 54 U.S. organ transplant rejection medicine market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 55 U.S. organ transplant rejection medicine market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 56 U.S. organ transplant rejection medicine market size, by transplant type, 2018 - 2022 (USD Million)
  • TABLE 57 U.S. organ transplant rejection medicine market size, by transplant type, 2023 - 2032 (USD Million)
  • TABLE 58 U.S. organ transplant rejection medicine market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 59 U.S. organ transplant rejection medicine market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 60 Canada organ transplant rejection medicine market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 61 Canada organ transplant rejection medicine market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 62 Canada organ transplant rejection medicine market size, by transplant type, 2018 - 2022 (USD Million)
  • TABLE 63 Canada organ transplant rejection medicine market size, by transplant type, 2023 - 2032 (USD Million)
  • TABLE 64 Canada organ transplant rejection medicine market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 65 Canada organ transplant rejection medicine market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 66 Europe organ transplant rejection medicine market size, by country, 2018 - 2022 (USD Million)
  • TABLE 67 Europe organ transplant rejection medicine market size, by country, 2023 - 2032 (USD Million)
  • TABLE 68 Europe organ transplant rejection medicine market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 69 Europe organ transplant rejection medicine market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 70 Europe organ transplant rejection medicine market size, by transplant type, 2018 - 2022 (USD Million)
  • TABLE 71 Europe organ transplant rejection medicine market size, by transplant type, 2023 - 2032 (USD Million)
  • TABLE 72 Europe organ transplant rejection medicine market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 73 Europe organ transplant rejection medicine market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 74 Germany organ transplant rejection medicine market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 75 Germany organ transplant rejection medicine market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 76 Germany organ transplant rejection medicine market size, by transplant type, 2018 - 2022 (USD Million)
  • TABLE 77 Germany organ transplant rejection medicine market size, by transplant type, 2023 - 2032 (USD Million)
  • TABLE 78 Germany organ transplant rejection medicine market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 79 Germany organ transplant rejection medicine market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 80 UK organ transplant rejection medicine market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 81 UK organ transplant rejection medicine market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 82 UK organ transplant rejection medicine market size, by transplant type, 2018 - 2022 (USD Million)
  • TABLE 83 UK organ transplant rejection medicine market size, by transplant type, 2023 - 2032 (USD Million)
  • TABLE 84 UK organ transplant rejection medicine market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 85 UK organ transplant rejection medicine market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 86 France organ transplant rejection medicine market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 87 France organ transplant rejection medicine market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 88 France organ transplant rejection medicine market size, by transplant type, 2018 - 2022 (USD Million)
  • TABLE 89 France organ transplant rejection medicine market size, by transplant type, 2023 - 2032 (USD Million)
  • TABLE 90 France organ transplant rejection medicine market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 91 France organ transplant rejection medicine market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 92 Spain organ transplant rejection medicine market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 93 Spain organ transplant rejection medicine market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 94 Spain organ transplant rejection medicine market size, by transplant type, 2018 - 2022 (USD Million)
  • TABLE 95 Spain organ transplant rejection medicine market size, by transplant type, 2023 - 2032 (USD Million)
  • TABLE 96 Spain organ transplant rejection medicine market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 97 Spain organ transplant rejection medicine market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 98 Italy organ transplant rejection medicine market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 99 Italy organ transplant rejection medicine market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 100 Italy organ transplant rejection medicine market size, by transplant type, 2018 - 2022 (USD Million)
  • TABLE 101 Italy organ transplant rejection medicine market size, by transplant type, 2023 - 2032 (USD Million)
  • TABLE 102 Italy organ transplant rejection medicine market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 103 Italy organ transplant rejection medicine market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 104 Switzerland organ transplant rejection medicine market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 105 Switzerland organ transplant rejection medicine market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 106 Switzerland organ transplant rejection medicine market size, by transplant type, 2018 - 2022 (USD Million)
  • TABLE 107 Switzerland organ transplant rejection medicine market size, by transplant type, 2023 - 2032 (USD Million)
  • TABLE 108 Switzerland organ transplant rejection medicine market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 109 Switzerland organ transplant rejection medicine market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 110 Rest of Europe organ transplant rejection medicine market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 111 Rest of Europe organ transplant rejection medicine market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 112 Rest of Europe organ transplant rejection medicine market size, by transplant type, 2018 - 2022 (USD Million)
  • TABLE 113 Rest of Europe organ transplant rejection medicine market size, by transplant type, 2023 - 2032 (USD Million)
  • TABLE 114 Rest of Europe organ transplant rejection medicine market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 115 Rest of Europe organ transplant rejection medicine market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 116 Asia Pacific organ transplant rejection medicine market size, by country, 2018 - 2022 (USD Million)
  • TABLE 117 Asia Pacific organ transplant rejection medicine market size, by country, 2023 - 2032 (USD Million)
  • TABLE 118 Asia Pacific organ transplant rejection medicine market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 119 Asia Pacific organ transplant rejection medicine market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 120 Asia Pacific organ transplant rejection medicine market size, by transplant type, 2018 - 2022 (USD Million)
  • TABLE 121 Asia Pacific organ transplant rejection medicine market size, by transplant type, 2023 - 2032 (USD Million)
  • TABLE 122 Asia Pacific organ transplant rejection medicine market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 123 Asia Pacific organ transplant rejection medicine market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 124 China organ transplant rejection medicine market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 125 China organ transplant rejection medicine market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 126 China organ transplant rejection medicine market size, by transplant type, 2018 - 2022 (USD Million)
  • TABLE 127 China organ transplant rejection medicine market size, by transplant type, 2023 - 2032 (USD Million)
  • TABLE 128 China organ transplant rejection medicine market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 129 China organ transplant rejection medicine market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 130 Japan organ transplant rejection medicine market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 131 Japan organ transplant rejection medicine market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 132 Japan organ transplant rejection medicine market size, by transplant type, 2018 - 2022 (USD Million)
  • TABLE 133 Japan organ transplant rejection medicine market size, by transplant type, 2023 - 2032 (USD Million)
  • TABLE 134 Japan organ transplant rejection medicine market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 135 Japan organ transplant rejection medicine market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 136 India organ transplant rejection medicine market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 137 India organ transplant rejection medicine market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 138 India organ transplant rejection medicine market size, by transplant type, 2018 - 2022 (USD Million)
  • TABLE 139 India organ transplant rejection medicine market size, by transplant type, 2023 - 2032 (USD Million)
  • TABLE 140 India organ transplant rejection medicine market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 141 India organ transplant rejection medicine market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 142 Australia organ transplant rejection medicine market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 143 Australia organ transplant rejection medicine market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 144 Australia organ transplant rejection medicine market size, by transplant type, 2018 - 2022 (USD Million)
  • TABLE 145 Australia organ transplant rejection medicine market size, by transplant type, 2023 - 2032 (USD Million)
  • TABLE 146 Australia organ transplant rejection medicine market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 147 Australia organ transplant rejection medicine market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 148 South Korea organ transplant rejection medicine market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 149 South Korea organ transplant rejection medicine market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 150 South Korea organ transplant rejection medicine market size, by transplant type, 2018 - 2022 (USD Million)
  • TABLE 151 South Korea organ transplant rejection medicine market size, by transplant type, 2023 - 2032 (USD Million)
  • TABLE 152 South Korea organ transplant rejection medicine market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 153 South Korea organ transplant rejection medicine market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 154 Rest of Asia Pacific organ transplant rejection medicine market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 155 Rest of Asia Pacific organ transplant rejection medicine market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 156 Rest of Asia Pacific organ transplant rejection medicine market size, by transplant type, 2018 - 2022 (USD Million)
  • TABLE 157 Rest of Asia Pacific organ transplant rejection medicine market size, by transplant type, 2023 - 2032 (USD Million)
  • TABLE 158 Rest of Asia Pacific organ transplant rejection medicine market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 159 Rest of Asia Pacific organ transplant rejection medicine market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 160 Latin America organ transplant rejection medicine market size, by country, 2018 - 2022 (USD Million)
  • TABLE 161 Latin America organ transplant rejection medicine market size, by country, 2023 - 2032 (USD Million)
  • TABLE 162 Latin America organ transplant rejection medicine market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 163 Latin America organ transplant rejection medicine market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 164 Latin America organ transplant rejection medicine market size, by transplant type, 2018 - 2022 (USD Million)
  • TABLE 165 Latin America organ transplant rejection medicine market size, by transplant type, 2023 - 2032 (USD Million)
  • TABLE 166 Latin America organ transplant rejection medicine market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 167 Latin America organ transplant rejection medicine market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 168 Brazil organ transplant rejection medicine market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 169 Brazil organ transplant rejection medicine market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 170 Brazil organ transplant rejection medicine market size, by transplant type, 2018 - 2022 (USD Million)
  • TABLE 171 Brazil organ transplant rejection medicine market size, by transplant type, 2023 - 2032 (USD Million)
  • TABLE 172 Brazil organ transplant rejection medicine market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 173 Brazil organ transplant rejection medicine market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 174 Mexico organ transplant rejection medicine market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 175 Mexico organ transplant rejection medicine market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 176 Mexico organ transplant rejection medicine market size, by transplant type, 2018 - 2022 (USD Million)
  • TABLE 177 Mexico organ transplant rejection medicine market size, by transplant type, 2023 - 2032 (USD Million)
  • TABLE 178 Mexico organ transplant rejection medicine market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 179 Mexico organ transplant rejection medicine market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 180 Rest of Latin America organ transplant rejection medicine market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 181 Rest of Latin America organ transplant rejection medicine market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 182 Rest of Latin America organ transplant rejection medicine market size, by transplant type, 2018 - 2022 (USD Million)
  • TABLE 183 Rest of Latin America organ transplant rejection medicine market size, by transplant type, 2023 - 2032 (USD Million)
  • TABLE 184 Rest of Latin America organ transplant rejection medicine market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 185 Rest of Latin America organ transplant rejection medicine market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 186 Middle East & Africa organ transplant rejection medicine market size, by country, 2018 - 2022 (USD Million)
  • TABLE 187 Middle East & Africa organ transplant rejection medicine market size, by country, 2023 - 2032 (USD Million)
  • TABLE 188 Middle East & Africa organ transplant rejection medicine market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 189 Middle East & Africa organ transplant rejection medicine market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 190 Middle East & Africa organ transplant rejection medicine market size, by transplant type, 2018 - 2022 (USD Million)
  • TABLE 191 Middle East & Africa organ transplant rejection medicine market size, by transplant type, 2023 - 2032 (USD Million)
  • TABLE 192 Middle East & Africa organ transplant rejection medicine market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 193 Middle East & Africa organ transplant rejection medicine market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 194 South Africa organ transplant rejection medicine market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 195 South Africa organ transplant rejection medicine market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 196 South Africa organ transplant rejection medicine market size, by transplant type, 2018 - 2022 (USD Million)
  • TABLE 197 South Africa organ transplant rejection medicine market size, by transplant type, 2023 - 2032 (USD Million)
  • TABLE 198 South Africa organ transplant rejection medicine market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 199 South Africa organ transplant rejection medicine market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 200 Saudi Arabia organ transplant rejection medicine market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 201 Saudi Arabia organ transplant rejection medicine market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 202 Saudi Arabia organ transplant rejection medicine market size, by transplant type, 2018 - 2022 (USD Million)
  • TABLE 203 Saudi Arabia organ transplant rejection medicine market size, by transplant type, 2023 - 2032 (USD Million)
  • TABLE 204 Saudi Arabia organ transplant rejection medicine market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 205 Saudi Arabia organ transplant rejection medicine market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 206 Rest of Middle East & Africa organ transplant rejection medicine market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 207 Rest of Middle East & Africa organ transplant rejection medicine market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 208 Rest of Middle East & Africa organ transplant rejection medicine market size, by transplant type, 2018 - 2022 (USD Million)
  • TABLE 209 Rest of Middle East & Africa organ transplant rejection medicine market size, by transplant type, 2023 - 2032 (USD Million)
  • TABLE 210 Rest of Middle East & Africa organ transplant rejection medicine market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 211 Rest of Middle East & Africa organ transplant rejection medicine market size, by distribution channel, 2023 - 2032 (USD Million)

Charts & Figures

  • FIG 1 GMI report coverage: Critical research elements
  • FIG 2 Top-down approach
  • FIG 3 Market estimation and forecast methodology
  • FIG 4 Market forecasting methodology
  • FIG 5 Breakdown of primary participants
  • FIG 6 Organ transplant rejection medicine industry 36 degree synopsis, 2018 - 2032
  • FIG 7 Growth potential analysis, by drug class
  • FIG 8 Growth potential analysis, by transplant type
  • FIG 9 Growth potential analysis, by distribution channel
  • FIG 10 Porter's analysis
  • FIG 11 PESTEL analysis
  • FIG 12 Company matrix analysis, 2022
  • FIG 13 Global company market share analysis, 2022
  • FIG 14 Competitive positioning matrix, 2022
  • FIG 15 Strategic dashboard, 2022
目次
Product Code: 6581

Organ Transplant Rejection Medication Market size is projected to expand at 3.2% CAGR from 2023-2032 attributed to the escalating frequency of chronic diseases and the rising necessity of organ transplants. The influx of lifestyle-related ailments and the growing burden of conditions, such as end-stage renal disease and liver failure are contributing to the surging demand for effective rejection medications.

Moreover, the scaling emphasis of healthcare providers on optimizing patient outcomes along with the continuous development of innovative immunosuppressive therapies tailored to combat organ rejection will fuel the market growth. To cite an instance, in September 2023, Eledon Pharmaceuticals, Inc. revealed that tegoprubart, its experimental anti-CD40 antibody, was employed as a key component in the chronic immunosuppressive treatment after the second-ever transplant of a genetically engineered heart from a pig to a person.

The organ transplant rejection medication industry is categorized by transplant type, distribution channel, drug class, and region.

The market share from the antibodies drug class segment is anticipated to gain significant traction between 2023 and 2032. The surging number of organ transplantation procedures across the globe is driving the need for effective immunosuppressive therapies to ensure improved patient outcomes. Of late, antibodies offering enhanced specificity and reduced adverse effects have gained widespread prominence. Additionally, the ongoing R&D initiatives focused on optimizing antibody-based therapies will support the segment growth.

Based on distribution channel, the organ transplant rejection medication market from the retail pharmacies segment is anticipated to record robust growth through 2032. The widespread network of retail pharmacies coupled with their accessibility and patient-centric approach are significantly facilitating the distribution of organ rejection medications. Furthermore, the rising need for personalized counseling and medication management services is contributing to the increased uptake of organ transplant rejection medications.

Regionally, the Asia Pacific organ transplant rejection medication industry is estimated to witness substantial growth through 2032, propelled by the increasing prevalence of organ transplantation procedures and the rising incidence of chronic diseases. Massive healthcare investments and advancements in medical infrastructure are contributing to the growing demand for effective immunosuppressive therapies to prevent transplant rejection. Moreover, the presence of large patient pool and the higher implementation of supportive government initiatives to enhance healthcare access will augment the regional industry outlook.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market definition
  • 1.2 Base estimates & calculations
  • 1.3 Forecast calculation
  • 1.4 Covid-19 impact analysis at global level
  • 1.5 Data validation
  • 1.6 Data sources
    • 1.6.1 Secondary
      • 1.6.1.1 Paid sources
      • 1.6.1.2 Public sources
    • 1.6.2 Primary

Chapter 2 Executive Summary

  • 2.1 Organ transplant rejection medication industry 360 degree synopsis, 2018 - 2032 (USD Million)
    • 2.1.1 Business trends
    • 2.1.2 Region trends
    • 2.1.3 Drug class trends
    • 2.1.4 Transplant type trends
    • 2.1.5 Distribution channel trends

Chapter 3 Organ Transplant Rejection Medication Market Insights

  • 3.1 Industry landscape, 2018 - 2032 (USD Million)
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing organ transplant procedures due to chronic diseases
      • 3.2.1.2 Technological advancements in organ transplantation and tissue engineering
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 High cost of organ transplantation procedures
      • 3.2.2.2 Low availability of organs for transplantation
  • 3.3 Growth potential analysis
    • 3.3.1 By drug class
    • 3.3.2 By transplant type
    • 3.3.3 By distribution channel
  • 3.4 COVID-19 impact analysis
  • 3.5 Regulatory landscape
  • 3.6 Porter's analysis
  • 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

  • 4.1 Introduction
  • 4.2 Company matrix analysis, 2022
  • 4.3 Competitive positioning matrix, 2022
  • 4.4 Strategic dashboard, 2022

Chapter 5 Organ Transplant Rejection Medication Market Estimates and Forecast, By Drug Class, 2018 - 2032 (USD Million)

  • 5.1 Key trends, by drug class
  • 5.2 Calcineurin inhibitors
  • 5.3 Antibodies
  • 5.4 Antiproliferative agents
  • 5.5 mTOR inhibitor
  • 5.6 Steroids

Chapter 6 Organ Transplant Rejection Medication Market Estimates and Forecast, By Transplant Type, 2018 - 2032 (USD Million)

  • 6.1 Key trends, by transplant type
  • 6.2 Kidney
  • 6.3 Liver
  • 6.4 Heart
  • 6.5 Lung
  • 6.6 Pancreas
  • 6.7 Other transplant types

Chapter 7 Organ Transplant Rejection Medication Market Estimates and Forecast, By Distribution Channel, 2018 - 2032 (USD Million)

  • 7.1 Key trends, by distribution channel
  • 7.2 Hospital pharmacies
  • 7.3 Retail pharmacies
  • 7.4 Online pharmacies

Chapter 8 Organ Transplant Rejection Medication Market Estimates and Forecast, By Region, 2018 - 2032 (USD Million)

  • 8.1 Key trends, by region
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Spain
    • 8.3.5 Italy
    • 8.3.6 Switzerland
    • 8.3.7 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
    • 8.4.6 Rest of Asia Pacific
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Rest of Latin America
  • 8.6 Middle East & Africa
    • 8.6.1 South Africa
    • 8.6.2 Saudi Arabia
    • 8.6.3 Rest of Middle East & Africa

Chapter 9 Company Profiles

  • 9.1 Astellas Pharma Inc.
  • 9.2 Sanofi
  • 9.3 Bristol-Myers Squibb Company
  • 9.4 Novartis AG
  • 9.5 F. Hoffmann-La Roche Ltd
  • 9.6 Accord Healthcare Ltd
  • 9.7 Viatris, Inc.
  • 9.8 Dr. Reddy's Laboratories Ltd
  • 9.9 Veloxis Pharmaceuticals A/S
  • 9.10 GlaxoSmithKline plc